International AIDS Conference

Here is will you will find the latest information in Vienna coming out on new treatments, and when to start treatments. The conference runs from July 18 - 24.

This section provides you with all the conference-related articles published all in one spot. Other non-conference, including what is found here can be found on my (Brian Finch, founder and publisher) blog, Acid Reflux on PositiveLite.com.

Reporting on the XVIII International AIDS Conference sponsored by Gilead Sciences Canada.

IAS names San Francisco and Oakland hosts of AIDS 2020

published: March, 14, 2018 Written by // Rob Olver - Editor Categories // International AIDS Conference , Social Media, Gay Men, Current Affairs, International , Media, Rob Olver - Editor

Over 50 Bay Area, US & Global Orgs representing key populations oppose AIDS 2020 in San Francisco. Rob Olver reports.

IAS names San Francisco and Oakland hosts of AIDS 2020

13 March 2018  – The International AIDS Society (IAS) has announced that San Francisco, California, in partnership with nearby Oakland, will host the 23rd International AIDS Conference (AIDS 2020) but that decision has already drawn fire. While the decision was hailed by Democratic Leader Nancy Pelosi as “fitting and deeply inspiring”, a letter released today by every major national network of people living with HIV in the U.S., along with other organizations and individuals calls

How much "PrEP-resistant" HIV is out there?

published: March, 12, 2018 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, Conferences, Gay Men, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Research, Health, International , Revolving Door, Treatment, Guest Authors, Media

From AIDSmap, Gus Cairns reports from the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018).

How much

A study presented at the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) aims to quantify how many people with HIV there might be in the community who both have a detectable HIV viral load and also have significant resistance to tenofovir and emtricitabine, the two drugs currently used in pre-exposure prophylaxis (PrEP). The researchers, from the University of Washington in Seattle, found that in King County, which contains Seattle, no more than 0.3% of the l

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

published: March, 07, 2018 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, Conferences, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Health, Research, International , Treatment, Revolving Door, Guest Authors, Media

Five of eleven treated animals still remained virally suppressed at six months. From AIDSmap, Liz Highleyman reports.

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

Dan Barouch presenting at CROI 2018. Photo by Liz Highleyman Treatment with a broadly neutralising antibody plus an immune-stimulating drug led to long-term viral remission after interrupting antiretroviral therapy in a monkey study, according to data presented at the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) this week in Boston. Monkeys that received both the antibody, known as PGT121, and the TLR7 agonist GS-9620 maintained an undetectable viral load withou

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

published: February, 26, 2018 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, As Prevention , Conferences, Current Affairs, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Media, Guest Authors, Opinion Pieces

From AIDSmap, Gus Cairns reports on the PrEP In Europe Summit 2018

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention, the first-ever European PrEP Summit, held in Amsterdam ten days ago, heard. Ignorance – among politicians, among healthcare workers, and among potential users of PrEP – was the main reason Europe lags far behind the USA in PrEP provision, despite there being a possibly more favourable climate in terms of p

Despite reassuring data, we can’t yet say U=U for breastfeeding

published: November, 27, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, International AIDS Conference , As Prevention , Current Affairs, Treatment Guidelines -including when to start, Research, International , Revolving Door, Treatment, Guest Authors, Media

Clinicians in high-income countries should take a harm reduction advice approach with HIV-positive mothers who breastfeed. From AIDSmap, Roger Pebody reports.

Despite reassuring data, we can’t yet say U=U for breastfeeding

While effective HIV treatment greatly reduces the risk of onward transmission during breastfeeding, it does not appear that the risk is zero, a leading paediatrician told the British HIV Association (BHIVA) conference in London last week. Although formula feeding is the safest option in high-income countries, some women will choose to breastfeed and healthcare professionals should support them to do so as safely as possible. Dr Hermione Lyall of St Mary's Hospital, London said that she and

HIV diagnoses in English gay men have been falling since 2014

published: November, 13, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, International AIDS Conference , As Prevention , Gay Men, Treatment Guidelines -including when to start, International , Treatment, Revolving Door, Guest Authors, Media

HIV diagnoses have fallen by 65% in London and by 48% outside London from their peak in 2014. From AIDSmap, Gus Cairns reports.

HIV diagnoses in English gay men have been falling since 2014

Noel Gill presenting at EACS 2017. Image credit: @caryjameslondon A new analysis by Public Health England of testing rates and HIV diagnoses from all of England’s sexual health clinics shows that the decline in diagnoses is England-wide, started at least a year before the decline was first noticed at London's 56 Dean Street clinic, and is not restricted to gay men who test frequently. One of the big stories in HIV prevention this year has been the dramatic drop in HIV diagnoses being s

People with HIV still expect a lower quality of life than their negative peers, European survey finds

published: October, 31, 2017 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, As Prevention , Treatment Guidelines -including when to start, Mental Health, Health, International , Revolving Door, Treatment, Living with HIV, Media, Guest Authors

Nearly 40% with an undetectable viral load still consider themselves infectious. Gus Cairns reports on a European study commissioned by Gilead Sciences.

People with HIV still expect a lower quality of life than their negative peers, European survey finds

A study commissioned by the drug company Gilead Sciences and conducted in five European countries has found that, compared with their HIV-negative peers, people with HIV still expect to die sooner and think they are less likely to achieve a long-term relationship. The results were announced yesterday during the 16th European AIDS Conference (EACS 2017) in Milan, Italy. The survey found that 54% of HIV-positive people considered HIV to be a barrier to sex with others, and of them 87% (47% o

Who are trans women acquiring HIV from? And are trans women's partners a hidden population?

published: September, 05, 2017 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, As Prevention , Treatment Guidelines -including when to start, General Health, Women, Research, Health, International , Treatment, Revolving Door, Guest Authors, Media

Is there a hidden population of heterosexual men who have sex with trans women and who are themselves at high risk of acquiring and transmitting HIV? From AIDSmap, Gus Cairns reports on a study that begs this question and others.

Who are trans women acquiring HIV from? And are trans women's partners a hidden population?

There is a lot we don’t know about trans women’s HIV risk, why they are so vulnerable to HIV and who trans women are acquiring HIV from. A study presented at last month’s 9th International AIDS Society Conference on HIV Science (IAS 2017) attempted to answer these questions, but in the process uncovered another mystery. This is whether there is a hidden population of heterosexual men who have sex with trans women and who are themselves at high risk of acquiring and transmitting HIV. On

No ordinary affair. IAS 2017 report from Paris, Part Two: U=U makes a huge splash

published: August, 01, 2017 Written by // Bob Leahy - Publisher Categories // Activism, International AIDS Conference , International , Living with HIV, Opinion Pieces, Bob Leahy - Publisher

Bob Leahy with an insider’s report on how U=U made a huge impression last week in Paris - in the conference centre, on it’s main stage and in the media.

No ordinary affair. IAS 2017 report from Paris, Part Two: U=U makes a huge splash

What people said? Some said that history was made at IAS2017 in Paris last week. I’m too close to the campaign to be objective – I lead the Canadian arm of the Prevention Access Campaign's work – but certainly it was a big week. It was also one where the U=U campaign repeatedly made the news. Important things were said by important people, including by us and about us – people living with HIV. Here are some of the things people said about U=U last week “Scientists never like to

No ordinary affair. IAS 2017 report from Paris, Part One: Conference highlights

published: August, 01, 2017 Written by // Bob Leahy - Publisher Categories // Activism, International AIDS Conference , Living with HIV, Bob Leahy - Publisher

Bob Leahy was in Paris last week covering the big IAS conference on HIV Science. Turns out it was the best he had been to and not just because Undetectable=Untransmittable (U=U) almost stole the show. Here is what else happened.

No ordinary affair. IAS 2017 report from Paris, Part One: Conference highlights

International AIDS Society Conferences come in two sizes. They alternate. Next year will be the big one in Amsterdam which deals with the whole panoply of HIV knowledge, including science and research and more. It will likely attract about 20,000 people. This year’s alternate year conference was just about HIV science, a smaller affair with 8,000 or so of us in attendance from 40 countries with an agenda less community-based. In other words, it was potentially a bit dull. This one certainl

International study of gay couples reports no transmissions from an HIV-positive partner on treatment

published: July, 27, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Activism, International AIDS Conference , As Prevention , Current Affairs, General Health, Treatment Guidelines -including when to start, Health, Research, Sexual Health, Treatment, Revolving Door, Guest Authors, Media

From AIDSmap, Gus Cairns reports on evidence from the Opposites Attract study that was presented this week at #IAS2017 in Paris.

International study of gay couples reports no transmissions from an HIV-positive partner on treatment

Image from Opposites Attract study: www.oppositesattract.net.au A study of 343 gay couples, where one partner had HIV and the other did not, has not found a single case of HIV transmission in 16,889 acts of condomless anal sex, the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris, France, was told today. The Opposites Attract study looked at whether HIV is transmitted between gay male couples of different HIV status when the HIV positive partner is on treatment

Paris bound

published: July, 13, 2017 Written by // Bob Leahy - Publisher Categories // International AIDS Conference , Living with HIV, Opinion Pieces, Bob Leahy - Publisher

Paris bound Publisher Bob Leahy is off to Paris for IAS 2017. It’s not all fun; here’s what he is looking forward to.

Paris bound

On July 20 I will be leaving the rolling green hills of Northumberland County, a quietly rural patch of Ontario, for the great city of Paris. I am fortunate enough to be representing PositiveLite.com at the International AIDS Society Conference there. (Officially it's called the 9yj IAS Conference on HIV Science.) It will attract some 5,000 attendees. You will see it referred to everywhere as #IAS2017. It will be the fifth international AIDS Conference I’ve had the privilege of covering, p

Applying for any community scholarship? What you should know.

published: May, 24, 2017 Written by // Bob Leahy - Publisher Categories // Activism, International AIDS Conference , Conferences, Living with HIV, Opinion Pieces, Bob Leahy - Publisher

Applying for a community scholarship? What you should know. Bob Leahy says it can be a frustrating experience which often leads to the big NO. But, he says, keep trying as persistence can pay off

 Applying for any community scholarship? What you should know.

HIV conferences are not for everyone, but they can be empowering, educational and a great way to interact with other people living with HIV. For those community members – people living with HIV – who would like to attend, though, it’s not easy. Simply put our attendance costs money – for travel and accommodation in particular. If you are not employed in the sector, and even if you are, the way to get there is usually to apply for a community scholarship which will fund your attendance

HIV’s milder cousin may be less mild than previously thought

published: March, 29, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, International AIDS Conference , Social Media, Conferences, Gay Men, Current Affairs, Research, Health, International , Revolving Door, Guest Authors, Media

Gus Cairns: Seventy per cent of people with HIV-2 progress to AIDS within 20 years

HIV’s milder cousin may be less mild than previously thought

HIV-2’s virulence may have been underestimated and although progression to AIDS  and death in HIV-2 infection was slower than with HIV-1, it was the rule rather than the exception, new research from West Africa presented at last month's Conference on Retroviruses and Opportunistic Infections (CROI 2017) indicates. HIV-2 crossed over into human beings from the sooty mangabey monkey, rather than from chimpanzees and gorillas like HIV-1. Its entry into humans probably precedes that of HIV

STI rates in PrEP users very high, but evidence that PrEP increases them is inconclusive

published: March, 17, 2017 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Conferences

AIDSmap.com's Gus Cairns: Modelling study predicts STI rates will fall with regular testing

STI rates in PrEP users very high, but evidence that PrEP increases them is inconclusive

A study of pre-exposure prophylaxis (PrEP) users presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2017) last week in Seattle, showed that PrEP users had very high rates of sexually transmitted infection (STI) diagnosis – in the order of 20 times higher than among HIV-negative gay men in the general population. There was also an increase in STI diagnoses from a time point a year before they sought PrEP to the date they started it. And the percentage of men r

[12 3 4 5  >>